Status | Study |
NOT_YET_RECRUITING |
Study Name: Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis Condition: Blepharoptosis Date: 2023-07-06 Interventions: Oxymetazoline was initially developed in 1961.It is a direct sympathomimetic, binding directly to alpha-1 and alpha-2 receptors.Current |
Active, not recruiting |
Study Name: Surgical Management of Blepharoptosis Condition: Blepharoptosis Date: 2017-05-08 Interventions: Procedure: levator muscle resection with fixed sutures technique |
Not yet recruiting |
Study Name: Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair Condition: Blepharoptosis Ptosis Date: 2016-10-31 Interventions: Procedure: Subconjunctival Injection |
Not yet recruiting |
Study Name: Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries Condition: Blepharoptosis Blepharochalasis, Superior Date: 2015-12-16 Interventions: Device: Cochet-Bonnet aesthesiometer The eyelid's sensatio |
Active, not recruiting |
Study Name: Magnetic Correction of Eye Lid Paralysis Condition: Blepharoptosis Lagophthalmos Date: 2015-10-01 Interventions: Device: Magnetic lid system Small externally mounted magnetic lid arrays are attached to the eye lid (s) |
Not yet recruiting |
Study Name: Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair Condition: Blepharoptosis Date: 2015-07-12 Interventions: Procedure: Levator advancement |
Completed |
Study Name: Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis Condition: Acquired Blepharoptosis Date: 2015-05-04 Interventions: Drug: RVL-1201 RVL-1201 Ophtha |
Completed |
Study Name: Digital Photographs to Evaluate Blepharoptosis Condition: Blepharoptosis Date: 2015-02-03 Interventions: Other: Method comparison |
Completed |
Study Name: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) Condition: Lower Eyelid Steatoblepharon (Excess Eyelid Fat) Date: 2014-08-28 Interventions: Drug: XOPH5 Ointment Drug: Placebo |
Terminated |
Study Name: Astigmatic Changes Secondary to Eyelid Surgeries Condition: Blepharoptosis Date: 2013-10-19 |